BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1909684)

  • 1. New markers for the neurofibromatosis-2 region generated by microdissection of chromosome 22.
    Fiedler W; Claussen U; Lüdecke HJ; Senger G; Horsthemke B; Geurts Van Kessel A; Goertzen W; Fahsold R
    Genomics; 1991 Jul; 10(3):786-91. PubMed ID: 1909684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of several DNA polymorphic markers in the LIF gene region.
    Moreau-Aubry A; Andre MT; Devilder MC; Resche F; Delattre O; Thomas G; Moisan JP
    Hum Genet; 1994 Oct; 94(4):450-1. PubMed ID: 7927349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress towards the isolation and characterization of the genes causing neurofibromatosis.
    Menon AG; Gusella JF; Seizinger BR
    Cancer Surv; 1990; 9(4):689-702. PubMed ID: 2129297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.
    Seizinger BR; Rouleau G; Ozelius LJ; Lane AH; St George-Hyslop P; Huson S; Gusella JF; Martuza RL
    Science; 1987 Apr; 236(4799):317-9. PubMed ID: 3105060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of chromosome 22 loci in meningioma. Alterations in the leukemia inhibitory factor (LIF) locus.
    Pergolizzi RG; Erster SH
    Mol Chem Neuropathol; 1994; 21(2-3):189-217. PubMed ID: 7916188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.
    Rouleau GA; Seizinger BR; Wertelecki W; Haines JL; Superneau DW; Martuza RL; Gusella JF
    Am J Hum Genet; 1990 Feb; 46(2):323-8. PubMed ID: 2105641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22.
    Rouleau GA; Wertelecki W; Haines JL; Hobbs WJ; Trofatter JA; Seizinger BR; Martuza RL; Superneau DW; Conneally PM; Gusella JF
    Nature; 1987 Sep 17-23; 329(6136):246-8. PubMed ID: 2888021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurofibromatosis--new clinical and molecular genetic aspects].
    Froster-Iskenius UG; Wolff HH
    Hautarzt; 1991 May; 42(5):279-83. PubMed ID: 1678737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma.
    Irving RM; Moffat DA; Hardy DG; Barton DE; Xuereb JH; Maher ER
    Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1222-8. PubMed ID: 8217082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred.
    Wertelecki W; Rouleau GA; Superneau DW; Forehand LW; Williams JP; Haines JL; Gusella JF
    N Engl J Med; 1988 Aug; 319(5):278-83. PubMed ID: 3134615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene for human leukemia inhibitory factor (LIF) maps to 22q12.
    Sutherland GR; Baker E; Hyland VJ; Callen DF; Stahl J; Gough NM
    Leukemia; 1989 Jan; 3(1):9-13. PubMed ID: 2491897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of 22q12 in a neurofibrosarcoma in neurofibromatosis type 1.
    Rey JA; Bello MJ; Kusak ME; de Campos JM; Pestaña A
    Cancer Genet Cytogenet; 1993 Mar; 66(1):28-32. PubMed ID: 8467471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning defined regions of the human genome by microdissection of banded chromosomes and enzymatic amplification.
    Lüdecke HJ; Senger G; Claussen U; Horsthemke B
    Nature; 1989 Mar; 338(6213):348-50. PubMed ID: 2784197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microdissection of the Prader-Willi syndrome chromosome region and identification of potential gene sequences.
    Buiting K; Neumann M; Lüdecke HJ; Senger G; Claussen U; Antich J; Passarge E; Horsthemke B
    Genomics; 1990 Mar; 6(3):521-7. PubMed ID: 2328991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A disease-associated germline deletion maps the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukaemia inhibitory factor locus.
    Watson CJ; Gaunt L; Evans G; Patel K; Harris R; Strachan T
    Hum Mol Genet; 1993 Jun; 2(6):701-4. PubMed ID: 8102569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and mapping of microdissected genomic clones from the adenomatous polyposis coli (APC) region.
    Hampton G; Leuteritz G; Lüdecke HJ; Senger G; Trautmann U; Thomas H; Solomon E; Bodmer WF; Horsthemke B; Claussen U
    Genomics; 1991 Oct; 11(2):247-51. PubMed ID: 1663069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct assignment of the human beta B2 and beta B3 crystallin genes to 22q11.2----q12: markers for neurofibromatosis 2.
    Hulsebos TJ; Bijlsma EK; Geurts van Kessel AH; Brakenhoff RH; Westerveld A
    Cytogenet Cell Genet; 1991; 56(3-4):171-5. PubMed ID: 2055112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human differentiation-stimulating factor (leukemia inhibitory factor, human interleukin DA) gene maps distal to the Ewing sarcoma breakpoint on 22q.
    Budarf M; Emanuel BS; Mohandas T; Goeddel DV; Lowe DG
    Cytogenet Cell Genet; 1989; 52(1-2):19-22. PubMed ID: 2558855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of twelve new RFLP-markers on chromosome 22q11-qter.
    Carlbom E; Sugawa N; Larsson C; Scambler PJ; Dumanski JP; Collins VP; Nordenskjöld M
    Hum Genet; 1991 Dec; 88(2):135-8. PubMed ID: 1684561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdissection and microcloning of human chromosome 7q22-32 region.
    Weber J; Weith A; Kaiser R; Grzeschik KH; Olek K
    Somat Cell Mol Genet; 1990 Mar; 16(2):123-8. PubMed ID: 1969681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.